Barrie Levitt This is Me

Education

 Web References

1. 1. PharmaLive

   www.engelpub.com/news/show_art - [Cached]

   Published on: 3/13/2003   Last Visited: 3/17/2003

   "Etodolac XL joins our other etodolac products, extending our oral dose product line and giving physicians important options in matching an arthritis therapy to the precise needs of their patients," said Barrie Levitt, M.D., Chairman of the Company. "We also market both etodolac immediate and extended-release tablets and capsules in Israel under the brand name Etopan(R)."
   
   Currently, Taro has 23 filings at the FDA: 20 ANDAs, including one tentative approval, two unique supplemental ANDAs and a New Drug Application related to the Company's NonSpil(TM) liquid drug delivery system. In addition, the Company has multiple regulatory filings in Canada, Israel and other countries around the world.
   
   Taro is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.

2. 2. PharmaLive

   www.medadnews.com/news/show_ar - [Cached]

   Published on: 2/19/2001   Last Visited: 8/10/2002

   "Amcinonide Cream broadens Taro's line of topical corticosteroids, providing additional options for doctors, pharmacists and patients who seek affordable, high-quality generic alternatives to branded drugs," said Barrie Levitt, M.D., Chairman of the Company. "Amcinonide is the latest product for which Taro manufactures the active pharmaceutical ingredient as well as the finished dosage form."
   
   Taro currently has 14 filings submitted to the FDA, and multiple international filings with regulatory agencies around the world.
   
   Taro is a multinational, science-based pharmaceutical company dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products.